RPO LLC’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

RPO LLC’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-36,083	Closed	-$371K	–	206
2022 Q4	$371K	Buy	+36,083	New	+$367K	0.13%	101

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

RPO LLC's IQMD Position: Q1 2023 in Review

RPO LLC sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 36,083 shares — an estimated $371K sold.

RPO LLC first reported a position in IQMD in Q4 2022 and held it in 1 quarter. The position peaked at $371K in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

RPO LLC reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
RPO LLC sold 36,083 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $371K.
RPO LLC first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2022 and held it in 1 quarter.
RPO LLC's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $371K in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on RPO LLC's 13F filing for Q1 2023, filed 11 May 2023.